Molbio-backed OptraSCAN receives USFDA 510(k) clearance for digital pathology system
Samsung Biologics to acquire PolyPeptide Group in CHF 1.46 billion deal
Emcure expands Poviztra indication to treat MASH following CDSCO approval of Wegovy
Agilus Diagnostics appoints Vijender Singh as MD & CEO
Viatris launches drug-resistant TB support project in Nagpur through PPP
Menthra Care launched in India to connect AI-based emotional support with mental health services
Alembic Pharma's partner NATCO secures tentative FDA approval for generic Olaparib tablets
USFDA issues one observation to Cipla's InvaGen plant after routine cGMP inspection
GPCB orders closure of Aarti Drugs' Saykha amines plant over environmental non-compliances
NHA charts next phase of Ayushman Bharat reforms with focus on AI, digital health and financial sustainability
The Indian approval is supported by Takeda's global clinical development program comprising 19 Phase I, II and III clinical trials involving more than 28,000 participants
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
_195_291.png){kind=logo}
